Market Overview:
The global ozanimod market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of autoimmune diseases, increasing R&D investments by pharmaceutical companies and growing demand for novel therapies. However, patent expiries of key products and stringent regulatory requirements are some of the major factors that could hamper the growth of this market during the forecast period. Based on type, the global ozanimod market is segmented into min purity less than 98%, min purity 98%-99% and min purity more than 99%. The min purity less than 98% segment is expected to account for a major share in terms of revenue in 2018 owing to high demand for low-cost drugs. However, with increasing R&D investments by pharmaceutical companies, this segment is projected to lose its share over the forecast period. The min purity more than 99% segment is anticipated to witness highest growth rate during 2018-2030 due mainly due increased adoption rates across developed countries such as U.S.
Product Definition:
Ozanimod is a novel, oral, selective sphingosine-1-phosphate receptor 1 (S1P1) and 5 (S1P5) modulator. It is indicated for the treatment of relapsing forms of multiple sclerosis.
Min Purity Less Than 98%:
Ozanimod is a drug that is developed for the treatment of multiple myeloma. It was first approved in 2014 in the U.S and has been gaining popularity ever since its approval owing to its effectiveness as an anti-cancer drug.
Min Purity 98%-99%:
Min Purity 98%-99% is a high purity grade of our standard 99.5%-99% pure powder form of ozanimod. It has the same quality and properties as that of commercialized products, however, it contains no additives or filler materials.
It is used to produce pharmaceutical-grade Ozanimod in China and other Asian countries for use in the U.S.
Application Insights:
Research application dominated the overall market in 2017. The growing number of R&D activities for cancer treatment and diagnosis is expected to be a key factor for product demand in this segment. Furthermore, increasing government funding and support for clinical research is also anticipated to have a positive impact on industry growth over the forecast period.
Medical application was the second largest segment in 2017 owing to rising awareness about cancer treatments among individuals across various regions of the world including North America, Europe, Asia Pacific and Middle East & Africa.
Regional Analysis:
In 2017, North America accounted for the largest share of over 55% in terms of revenue. The U.S., in particular, is one of the most important markets for ozanimod due to its advanced healthcare infrastructure and high patient awareness levels coupled with relatively higher healthcare spending capacities compared to other developing nations. In addition, ongoing clinical trials by various companies as well as FDA approvals are expected to fuel market growth during the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions during the forecast period owing to growing product demand from countries such as China and India along with Japan where several clinical trials are being conducted or are underway at present.
Growth Factors:
- Ozanimod is a novel, oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of relapsing forms of multiple sclerosis (MS) and ulcerative colitis (UC).
- The drug has a favorable safety profile with a low incidence of adverse events.
- Ozanimod has demonstrated efficacy in both MS and UC clinical trials, which could lead to increased market share over existing therapies.
- There is potential for ozanimod to be used as a first-line therapy for MS and UC patients due to its favorable safety profile and efficacy data.
- The drug is currently in Phase III development, which could lead to FDA approval and commercialization in the near future
Scope Of The Report
Report Attributes
Report Details
Report Title
Ozanimod Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Adooq Bioscience, Cayman Chemical, Biosynth Carbosynth, BioVision, BOC Sciences, AbMole, United States Biological, APExBIO Technology, Biorbyt, Selleck Chemicals, Clearsynth, Toronto Research Chemicals, Taiclone, BioCrick BioTech, Ark Pharm, KareBay Biochem, TargetMol
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Ozanimod Market Report Segments:
The global Ozanimod market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adooq Bioscience
- Cayman Chemical
- Biosynth Carbosynth
- BioVision
- BOC Sciences
- AbMole
- United States Biological
- APExBIO Technology
- Biorbyt
- Selleck Chemicals
- Clearsynth
- Toronto Research Chemicals
- Taiclone
- BioCrick BioTech
- Ark Pharm
- KareBay Biochem
- TargetMol
Highlights of The Ozanimod Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ozanimod Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ozanimod is a drug that is used to treat multiple sclerosis (MS). Ozanimod works by slowing the progression of the disease.
Some of the major players in the ozanimod market are Adooq Bioscience, Cayman Chemical, Biosynth Carbosynth, BioVision, BOC Sciences, AbMole, United States Biological, APExBIO Technology, Biorbyt, Selleck Chemicals, Clearsynth, Toronto Research Chemicals, Taiclone, BioCrick BioTech, Ark Pharm, KareBay Biochem, TargetMol.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ozanimod Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ozanimod Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ozanimod Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ozanimod Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ozanimod Market Size & Forecast, 2020-2028
4.5.1 Ozanimod Market Size and Y-o-Y Growth
4.5.2 Ozanimod Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ozanimod Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ozanimod Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ozanimod Market: Competitive Dashboard
14.2 Global Ozanimod Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Adooq Bioscience
14.3.2 Cayman Chemical
14.3.3 Biosynth Carbosynth
14.3.4 BioVision
14.3.5 BOC Sciences
14.3.6 AbMole
14.3.7 United States Biological
14.3.8 APExBIO Technology
14.3.9 Biorbyt
14.3.10 Selleck Chemicals
14.3.11 Clearsynth
14.3.12 Toronto Research Chemicals
14.3.13 Taiclone
14.3.14 BioCrick BioTech
14.3.15 Ark Pharm
14.3.16 KareBay Biochem
14.3.17 TargetMol
